dividend

Labcorp Board Initiates Quarterly Dividend, Approves $2.5B Share Repurchase Program

The dividend will be initiated in the second quarter of 2022, with the board targeting a dividend payout ratio of between 15 and 20 percent of adjusted earnings.

Bio-Techne Q4 Revenues Drop 8 Percent

The firm said that its Diagnostics and Genomics segment sales were essentially flat, while its Protein Sciences segment sales were down 11 percent during Q4.

dividend

Labcorp Board Initiates Quarterly Dividend, Approves $2.5B Share Repurchase Program

Bio-Techne Q4 Revenues Drop 8 Percent

Genetic Technologies to Raise A$5M in Direct Stock Offering

MDxHealth Prices $40M Public Offering

In Brief This Week: Meridian Bioscience, BARDA, HHS, Oncocyte, GeneDx, More

Siemens Healthineers Q1 Dx Revenues Fall 21 Percent; Firm Strikes Lab Analyzer Deal With Unilabs

Becton Dickinson Fiscal Q1 Revenues Down 3 Percent; Firm Raises FY23 Guidance

Roche Diagnostics Revenues Essentially Flat in 2022